These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26731018)
1. Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain. Thirstrup K; Sotty F; Montezinho LC; Badolo L; Thougaard A; Kristjánsson M; Jensen T; Watson S; Nielsen SM Pharmacol Res; 2016 Feb; 104():197-205. PubMed ID: 26731018 [TBL] [Abstract][Full Text] [Related]
2. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases. Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577 [TBL] [Abstract][Full Text] [Related]
3. Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing Drosophila larval model of Alzheimer's disease. Sinadinos C; Quraishe S; Sealey M; Samson PB; Mudher A; Wyttenbach A J Alzheimers Dis; 2013; 33(4):1117-33. PubMed ID: 23114515 [TBL] [Abstract][Full Text] [Related]
4. Hsp90 activator Aha1 drives production of pathological tau aggregates. Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation. Thompson AD; Scaglione KM; Prensner J; Gillies AT; Chinnaiyan A; Paulson HL; Jinwal UK; Dickey CA; Gestwicki JE ACS Chem Biol; 2012 Oct; 7(10):1677-86. PubMed ID: 22769591 [TBL] [Abstract][Full Text] [Related]
6. Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Pratt WB; Gestwicki JE; Osawa Y; Lieberman AP Annu Rev Pharmacol Toxicol; 2015; 55():353-71. PubMed ID: 25292434 [TBL] [Abstract][Full Text] [Related]
7. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350 [TBL] [Abstract][Full Text] [Related]
8. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting. Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516 [TBL] [Abstract][Full Text] [Related]
10. A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism. Wang B; Liu Y; Huang L; Chen J; Li JJ; Wang R; Kim E; Chen Y; Justicia C; Sakata K; Chen H; Planas A; Ostrom RS; Li W; Yang G; McDonald MP; Chen R; Heck DH; Liao FF Mol Psychiatry; 2017 Jul; 22(7):990-1001. PubMed ID: 27457810 [TBL] [Abstract][Full Text] [Related]
11. Chaperones increase association of tau protein with microtubules. Dou F; Netzer WJ; Tanemura K; Li F; Hartl FU; Takashima A; Gouras GK; Greengard P; Xu H Proc Natl Acad Sci U S A; 2003 Jan; 100(2):721-6. PubMed ID: 12522269 [TBL] [Abstract][Full Text] [Related]
12. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system. Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476 [TBL] [Abstract][Full Text] [Related]
13. Heat shock proteins at the crossroads between cancer and Alzheimer's disease. Wang H; Tan MS; Lu RC; Yu JT; Tan L Biomed Res Int; 2014; 2014():239164. PubMed ID: 25147790 [TBL] [Abstract][Full Text] [Related]
14. Protective role of heat shock proteins in Parkinson's disease. Aridon P; Geraci F; Turturici G; D'Amelio M; Savettieri G; Sconzo G Neurodegener Dis; 2011; 8(4):155-68. PubMed ID: 21212626 [TBL] [Abstract][Full Text] [Related]
15. Substrate transfer from the chaperone Hsp70 to Hsp90. Wegele H; Wandinger SK; Schmid AB; Reinstein J; Buchner J J Mol Biol; 2006 Feb; 356(3):802-11. PubMed ID: 16403523 [TBL] [Abstract][Full Text] [Related]
16. Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization. Kudryavtsev VA; Khokhlova AV; Mosina VA; Selivanova EI; Kabakov AE PLoS One; 2017; 12(3):e0173640. PubMed ID: 28291803 [TBL] [Abstract][Full Text] [Related]
17. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines. Håvik B; Bramham CR Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411 [TBL] [Abstract][Full Text] [Related]
18. FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70. Wang Y; Wang SY; Zhang XH; Zhao M; Hou CM; Xu YJ; Du ZY; Yu XD Biochem Biophys Res Commun; 2007 May; 356(4):998-1003. PubMed ID: 17397803 [TBL] [Abstract][Full Text] [Related]
19. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox. Okada M; Itoh H; Hatakeyama T; Tokumitsu H; Kobayashi R Biochem J; 2003 Sep; 374(Pt 2):433-41. PubMed ID: 12803546 [TBL] [Abstract][Full Text] [Related]
20. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease. Blair LJ; Sabbagh JJ; Dickey CA Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]